Literature DB >> 24979566

Development of gastric cancer and its prevention.

Sadegh Massarrat1, Manfred Stolte2.   

Abstract

Gastric cancer is a heterogeneous disorder; genetic factors, H. pylori infection and various environmental factors contribute to its development. Advanced atrophic corpus-predominant gastritis provides the histological base for its genesis. Low socio-economic status and poor hygienic conditions, smoking habits, heavy alcohol consumption, high salt and low intake of vegetables and fruits are important external factors for the occurrence of gastric cancer. For its prevention, the eradication of H. pylori infection at an early age is mandatory for subjects at high risk or those living in areas with high prevalence of gastric cancer. Given that an increased serum level of Pepsinogen II is a good biomarker for the presence of gastritis, it seems reasonable to screen all infected subjects at risk of gastric cancer with increased serum pepsinogen II at an early age (at around 30 years) to eradicate H. pylori. An endoscopy should be performed for subjects at an older age (40 years and older), when increased serum pepsinogen II level is associated with decreased serum pepsinogen I and pepsinogen I to II ratio.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24979566     DOI: 0141707/AIM.0013

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  12 in total

1.  Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.

Authors:  Genki Mori; Takeshi Nakajima; Kiyoshi Asada; Taichi Shimazu; Nobutake Yamamichi; Takao Maekita; Chizu Yokoi; Mitsuhiro Fujishiro; Takuji Gotoda; Masao Ichinose; Toshikazu Ushijima; Ichiro Oda
Journal:  Gastric Cancer       Date:  2015-09-29       Impact factor: 7.370

Review 2.  Towards curative therapy in gastric cancer: Faraway, so close!

Authors:  Marília Cravo; Catarina Fidalgo; Rita Garrido; Tânia Rodrigues; Gonçalo Luz; Carolina Palmela; Marta Santos; Fábio Lopes; Rui Maio
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 3.  Gastric cancer: epidemiology, prevention, classification, and treatment.

Authors:  Robert Sitarz; Małgorzata Skierucha; Jerzy Mielko; G Johan A Offerhaus; Ryszard Maciejewski; Wojciech P Polkowski
Journal:  Cancer Manag Res       Date:  2018-02-07       Impact factor: 3.989

4.  Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways.

Authors:  Yuanhang Li; Weijun Bai; Xu Zhang
Journal:  Mol Med Rep       Date:  2017-12-20       Impact factor: 2.952

5.  Gastric cancer patients display a distinctive population of IFNg+IL10+ double positive CD8 T cells, which persists longer during prolonged activation.

Authors:  Chen Zhong; Zongchang Song; Min Li
Journal:  Exp Cell Res       Date:  2019-06-28       Impact factor: 3.905

6.  Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4.

Authors:  Ting Guo; Yan-Hua Bai; Xiao-Jing Cheng; Hai-Bo Han; Hong Du; Ying Hu; Shu-Qin Jia; Xiao-Fang Xing; Jia-Fu Ji
Journal:  Cancer Commun (Lond)       Date:  2021-02-11

7.  Salivary Microbiota for Gastric Cancer Prediction: An Exploratory Study.

Authors:  Kun Huang; Xuefeng Gao; Lili Wu; Bin Yan; Zikai Wang; Xiaomei Zhang; Lihua Peng; Jiufei Yu; Gang Sun; Yunsheng Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-10       Impact factor: 5.293

Review 8.  Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.

Authors:  Jian-Peng Gao; Wei Xu; Wen-Tao Liu; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

9.  Expression of miR-23a and miR-135 and tumor markers in gastric cancer patients and the significance in diagnosis.

Authors:  Likui Yin; Guangxiao Xu; Yuntao Zhu; Yongqiang Wang
Journal:  Oncol Lett       Date:  2019-10-01       Impact factor: 2.967

10.  Comprehensive Analysis of a circRNA-miRNA-mRNA Network to Reveal Potential Inflammation-Related Targets for Gastric Adenocarcinoma.

Authors:  YunXia Liu; YeFeng Xu; Feng Xiao; JianFeng Zhang; YiQing Wang; YongWei Yao; JieWen Yang
Journal:  Mediators Inflamm       Date:  2020-08-01       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.